<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e> (IBD), <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, are T cell-mediated diseases that are characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing <z:mp ids='MP_0001845'>inflammation</z:mp> of the intestinal tract </plain></SENT>
<SENT sid="1" pm="."><plain>The pathogenesis of IBD involves the complex interaction between the intestinal microflora, host genetic and immune factors, and environmental stimuli </plain></SENT>
<SENT sid="2" pm="."><plain>Epidemiological analyses have implicated <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0014335" disease_type="Disease or Syndrome" abbrv="">enteritis</z:e> as one of the factors that may incite or exacerbate IBD in susceptible individuals </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, we examine how interactions between the common enteric pathogen Campylobacter jejuni (C. jejuni), the host intestinal epithelium, and resident intestinal microflora may contribute to the pathogenesis of IBD </plain></SENT>
<SENT sid="4" pm="."><plain>Recent experimental evidence indicates that C. jejuni may permit the translocation of <z:mpath ids='MPATH_458'>normal</z:mpath>, noninvasive microflora via novel processes that implicate epithelial <z:chebi fb="23" ids="18059">lipid</z:chebi> rafts </plain></SENT>
<SENT sid="5" pm="."><plain>This breach in intestinal barrier function may, in turn, prime the intestine for <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammatory responses</z:mp> in susceptible individuals </plain></SENT>
<SENT sid="6" pm="."><plain>Insights into the interactions between enteric pathogens, the host epithelia, and intestinal microflora will improve our understanding of disease processes that may initiate and/or exacerbate <z:mp ids='MP_0001858'>intestinal inflammation</z:mp> in patients with IBD and provide impetus for the development of new therapeutic approaches for the treatment of IBD </plain></SENT>
</text></document>